Drug Shortage Report for PMS-RANITIDINE 300 MG

Last updated on 2021-12-08 History
Report ID 98843
Drug Identification Number 02242454
Brand name PMS-RANITIDINE 300 MG
Common or Proper name RANITIDINE 300 MG
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) RANITIDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-23
Estimated end date
Actual end date 2021-12-07
Shortage status Resolved
Updated date 2021-12-08
Company comments **** DISCONTINUED ****
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-12-08 French Compare
v3 2021-12-08 English Compare
v2 2019-11-15 French Compare
v1 2019-11-15 English Compare

Showing 1 to 4 of 4